|
Similar Posts
National Alliance for Medication Assisted Recovery 435 Second Avenue New York, NY 10010
Membership Application Name: _______________________________________________________ Mr. ___ Ms. ___ Dr. ___ Organization: __________________________________________________________________________ Title: _____________________________________________ Degree(s): ________________________ Address: _____________________________________________________________________________ Address: _____________________________________________________________________________ City: __________________________________ State: ____________ Postal Code: _____________ Email: ______________________________________ Country: ________________________________ Home Phone: (____)___________________________ Work Phone: (____)_______________________ Alternate Phone: (____)________________________ Fax: (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail) Yes _____ No _____ Types of Membership $_______ Individual Membership Dues: $25 a…
Citation Instructions
NAMA produces materials for education and disemination. You are free to use them in your publications, or to discribute them. These are intended only as examples. Education Series author, name of document. Education Series, Number X, date. Available from National Alliance of Methadone Advocates, 435 Second Avenue, New York, NY 10010. Policy Statement name of…
Executive Report-3
National Alliance of Methadone Advocates The President’s Office Joycelyn Woods Executive Report DRAFT New York State Regulations, Page 3 of 5 Go to Page 4
Publication
The Methadone Alliance. Euromethwork Newsletter Mar. 2000, Issue 18. The Methadone Alliance supports people who receive prescribed drugs for the treatment of their drug dependency. We are users and sympathetic professionals working together as equals in a unique initiative to give drug users a voice in the drug policy debate. The Methadone Alliance actively promotes…
Food and Drug Administration Alert
T01-15 April 20, 2001 Print Media: 301-827-6242 Broadcast Media: 301-827-3434 Consumer Inquiries: 888-INFO-FDA FDA Warns About Orlaam The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With Addiction…